scispace - formally typeset
A

Ali T. Taher

Researcher at American University of Beirut

Publications -  630
Citations -  16642

Ali T. Taher is an academic researcher from American University of Beirut. The author has contributed to research in topics: Thalassemia & Deferasirox. The author has an hindex of 57, co-authored 595 publications receiving 13810 citations. Previous affiliations of Ali T. Taher include University of Balamand & Drug Abuse Resistance Education.

Papers
More filters
Journal ArticleDOI

2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.

Dominique Farge, +98 more
- 01 Oct 2019 - 
TL;DR: The 2019 International Initiative on Thrombosis and Cancer clinical practice guidelines, which are based on a systematic review of the literature published up to December, 2018, are presented along with a Grading of Recommendations Assessment Development and Evaluation scale methods.

Guidelines for the Management of Transfusion Dependent Thalassaemia (TDT)

TL;DR: The third edition of the TIF guidelines was published by Musallam et al. as mentioned in this paper and includes updated information on new approaches for more effective, safe and less laborious treatment, and an overview of the progress achieved to date towards a total cure using methods such as gene therapy and stem cell transplantation.
Journal ArticleDOI

Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: The optimal care study

TL;DR: Evidence is provided that calls for prospective evaluation of the roles of transfusion, iron chelation, and hydroxyurea therapy in TI patients that was protective for thrombosis, EMH, PHT, heart failure, cholelithiasis, and leg ulcers.
Journal ArticleDOI

Thalassemia intermedia: Revisited

TL;DR: There are no clear guidelines for initiating and maintaining transfusions in thalassemia intermedia for the prevention or treatment of complications, but some therapeutic strategies based on retrospective clinical observations are suggested.